Journal article icon

Journal article

Use of FGF-21 as a biomarker of mitochondrial disease in clinical practice

Abstract:

Recent work has suggested that fibroblast growth factor-21 (FGF-21) is a useful biomarker of mitochondrial disease (MD). We routinely measured FGF-21 levels on patients who were investigated at our centre for MD and evaluated its diagnostic performance based on detailed genetic and other laboratory findings. Patients' FGF-21 results were assessed by the use of age-adjusted z-scores based on normalised FGF-21 values from a healthy population. One hundred and fifty five patients were investigat...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.3390/jcm6080080

Authors


Morovat, A More by this author
Weerasinghe, G More by this author
Nesbitt, V More by this author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Pathology Dunn School
Expand authors...
More from this funder
Funding agency for:
Poulton, J
Publisher:
MDPI Publisher's website
Journal:
Journal of Clinical Medicine Journal website
Volume:
6
Issue:
8
Pages:
Article: 80
Publication date:
2017-08-21
Acceptance date:
2017-08-02
DOI:
ISSN:
2077-0383
Pubs id:
pubs:724247
URN:
uri:1bd9ea68-0369-4a60-b2e0-29032e9e61b7
UUID:
uuid:1bd9ea68-0369-4a60-b2e0-29032e9e61b7
Local pid:
pubs:724247

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP